Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
Submitted by
admin
on March 12, 2011 - 1:53pm
Source:
PR NewsWire
News Tags:
Sclor Pharma
pseudoephedrine
Headline:
SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
Do Not Allow Advertisers to Use My Personal information
